CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim
September 12, 2024 08:00 ET
|
CVRx, Inc.
New data published in JACC: Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life measures in heart failure patients with reduced ejection fraction MINNEAPOLIS, Sept. 12,...
CVRx Announces Appointment of Two New Board Members
September 03, 2024 08:30 ET
|
CVRx, Inc.
MINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointments of Kevin Ballinger and Mitch Hill to...
CVRx Announces Increased Inpatient Payment for Barostim Procedure
August 02, 2024 08:00 ET
|
CVRx, Inc.
MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services (CMS)...
CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference
July 31, 2024 16:27 ET
|
CVRx, Inc.
MINNEAPOLIS, July 31, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Canaccord...
CVRx Reports Second Quarter 2024 Financial and Operating Results
July 29, 2024 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, July 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024
July 15, 2024 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer
June 25, 2024 06:50 ET
|
CVRx, Inc.
MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer...
CVRx to Present at the William Blair 44th Annual Growth Stock Conference
May 22, 2024 08:30 ET
|
CVRx, Inc.
MINNEAPOLIS, May 22, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the William...
CVRx Announces Key Senior Leadership Team Hires
May 16, 2024 07:30 ET
|
CVRx, Inc.
Dr. Philip B. Adamson will join as Chief Medical OfficerBonnie Handke will join as Senior Vice President of Patient Access, Reimbursement, and Healthcare EconomicsJennifer E. Englund joins as Senior...
CVRx Reports First Quarter 2024 Financial and Operating Results
April 30, 2024 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...